8 Recruiting Prostatic Neoplasms Phase 1 Clinical Trials
Active phase 1 studies for prostatic neoplasms enrolling across the USA. Verify eligibility and contact site coordinators.
All Prostatic Neoplasms studiesPhase 1 Studies for Prostatic Neoplasms
🔵 Active, Not Recruiting Phase1
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
📍 Clinical Research Facility — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
📍 Columbia University Medical Center Herbert Irving Pavilion — New York, New York
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
📍 START Mountain Region — West Valley City, Utah
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
📍 Florida Cancer Specialists — Sarasota, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
📍 Houston Methodist — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
📍 Florida Cancer Specialists — Sarasota, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
📍 University of Colorado Anschutz Medical Campus — Aurora, Colorado
View Study & Checklist ➔